Pharmaceuticals In 2021, the Indian government launched a dedicated PLI scheme to bolster the country's pharmaceutical manufacturing base. Under this scheme, eligible manufacturers are categorized into three groups (A, B, and C) and offered incentives corresponding to their respective groups. The pharmaceuticals & drugs sector investments have already surpassed the expected investment amount under the PLI scheme, INR 25,813 Cr. as compared to INR 17,275 Cr. by 2023. |